Skip to Main Content
Pharmacy Technician's Letter
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Opioid Resources
    • Transitions of Care Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • NABP
    • National Certification
    • Additional Requirements
    • Exemptions
  • Podcasts
  • New Drugs
    • New Drugs
    • First Time Generics
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Interactions
  4. Gastroenterology
  5. Other

Other

  • Bone & Joint (55)
  • Cardiology (218)
  • Dermatology (49)
  • Diabetes & Endocrinology (37)
  • Gastroenterology (70)
    • Antacids (23)
    • Cisapride (8)
    • H2 Receptor Antagonists (7)
    • Other (18)
    • PPIs (30)
  • Hematology & Oncology (7)
  • Infectious Diseases (193)
  • Men's Health (6)
  • Natural Medicines / Supplements / Food Interactions (139)
  • Neurology (128)
  • Nutrition & Obesity (10)
  • Psychiatry (133)
  • Resources (34)
  • Respiratory & Allergy (22)
  • Transplant Meds (13)
  • Women's Health (44)
1 - 15 of 18 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Hepatitis C Treatment Overview July 2019
Chart: Treatment of Mild to Moderate Ulcerative Colitis April 2019
FAQ: Travelers’ Diarrhea: FAQs February 2019
Chart: Management of Chemo-Induced Nausea and Vomiting February 2018
Technician Tutorial: Drug Interactions 101 March 2017
Article: Encourage Epclusa Patients to Refill Their Hepatitis C Med Several Days Early September 2016
Other: Hepatitis C: What Pharmacy Technicians Need to Know September 2016
Article: Help Spot Patients Prescribed Amiodarone and Harvoni June 2015
Other: Sofosbuvir Interaction with Amiodarone June 2015
Article: Expect Chemo Patients to be on More Than One Antiemetic December 2014
Article: Keep Harvoni for Hepatitis C in its Original Container December 2014
Article: Uceris (u-SAIR-us, budesonide) for treating mild to moderate cases of ulcerative colitis March 2013
Article: Ondansetron (Zofran, etc) will join the list of drugs getting stronger warnings about "QT prolongation" December 2011
Article: confusion over interaction alerts between oral potassium chloride (Micro-K, etc) and certain INHALED meds (Spiriva, etc) October 2011
Commentary: Potassium and Anticholinergic Drug Interaction October 2011
  • 1
  • 2
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • News and Resources
  • Products
  • Individual Solutions
  • Enterprise Solutions
© Therapeutic Research Center. All Rights Reserved